financetom
ANIP
financetom
/
Healthcare
/
ANIP
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
ANI Pharmaceuticals, Inc.ANIP
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.

It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products.

The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products.

It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations.

ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Latest News >
Harley CEO Zeitz plans to retire in 2025
Harley CEO Zeitz plans to retire in 2025
Apr 8, 2025
April 8 (Reuters) - Harley-Davidson's ( HOG ) Jochen Zeitz plans to retire as CEO in 2025 after five years in the role, the American motorcycle maker said on Tuesday. Zeitz, hailed for turning around German footwear brand Puma's near-bankrupt business, joined Harley's board in 2007 and was tapped as CEO in May 2020. At Harley, Zeitz launched the Hardwire...
Kura Oncology Submits Ziftomenib NDA to FDA for Treating Acute Myeloid Leukemia
Kura Oncology Submits Ziftomenib NDA to FDA for Treating Acute Myeloid Leukemia
Apr 8, 2025
08:44 AM EDT, 04/08/2025 (MT Newswires) -- Kura Oncology ( KURA ) said Tuesday it submitted a new drug application to the US Food and Drug Administration for ziftomenib to potentially treat adults with relapsed or refractory acute myeloid leukemia with an NPM1 mutation. The biotechnology company said the FDA has 60 days to determine if the NDA is complete...
Ripple Shelves IPO Plans Even After SEC Lawsuit Closure, Says President at Paris Blockchain Week
Ripple Shelves IPO Plans Even After SEC Lawsuit Closure, Says President at Paris Blockchain Week
Apr 8, 2025
The lawsuit closure between Ripple and the SEC, as well as the changing atmosphere in the US regulatory landscape, will benefit the entire crypto industry, said the formers president, Monica Long, during the current Paris Blockchain Week conference. However, she poured cold water on recent reports that her company plans to go public anytime soon. Monica Long at PBW Long...
UBS Sees Short-Term US Dollar-Canadian Dollar Upside Risks
UBS Sees Short-Term US Dollar-Canadian Dollar Upside Risks
Apr 8, 2025
08:43 AM EDT, 04/08/2025 (MT Newswires) -- The Canadian dollar (CAD or loonie) outperformed high-beta peers around the globe on Liberation Day last week when the United States introduced reciprocal trade tariffs as Canada was left out of the list of tariffed nations, said UBS. The major question is whether Canada is off the hook for good or merely bought...
Copyright 2023-2026 - www.financetom.com All Rights Reserved